
Overdose deaths in the United States have been climbing for decades, and the drug landscape has shifted substantially over that time.
Behind each statistic is a human story, a family seeking hope, and a person deserving of a pathway toward healing. At Serenity Lane, we see the consequences of these substances every day.
The word "dangerous" means something different depending on who is using it and what they are measuring. A drug's harm profile is not a single number – it is a combination of factors that vary by substance, by person, and by context. Researchers and public health agencies assess drug-related harm across several overlapping dimensions, and the picture that emerges is more complicated than any single ranking suggests.
The following chart maps the factors that are used to evaluate how harmful a drug is:
| Factor | What It Measures |
|---|---|
| Overdose risk | How easily a toxic or lethal dose can be reached, and how narrow the margin is between a typical use dose and a fatal one |
| Physical dependence | How quickly and severely the body adapts to the drug and experiences withdrawal when use stops |
| Psychological dependence | The degree to which continued use feels compulsory, and how difficult stopping becomes over time |
| Long-term organ damage | Cumulative effects on the brain, heart, liver, lungs, or other systems with repeated exposure |
| Polysubstance risk | Whether the drug becomes significantly more dangerous when combined with other substances |
| Social harm | Broader effects on relationships, employment, housing, and community |
Alcohol scores high on organ damage and social harm. Fentanyl scores high on overdose risk because its lethal dose is so small. Methamphetamine scores high on cardiovascular consequences and psychological dependence. Benzodiazepines become significantly more dangerous when combined with other depressants.
Keeping this in mind makes it easier to understand why some substances cause enormous harm without producing many acute overdose deaths, and why legal status tells you very little about actual danger.

Nationally, the substances associated with the highest rates of death, hospitalization, and long-term health consequences are fentanyl and other synthetic opioids, methamphetamine, alcohol, cocaine, prescription opioids, and benzodiazepines.
A study published in the Journal of the American Heart Association found substance-use-related cardiovascular deaths rose 4% per year from 1999 to 2019, with alcohol linked to 65% in 2024.
Here is where each substance category currently stands in terms of its contribution to harm in the United States:
The most dangerous drugs are the ones that combine high availability, significant dependence potential, and serious health consequences – often in populations with limited access to treatment.
Alcohol's legal status creates a widespread perception that it is less dangerous than illicit drugs – but that perception is not supported by the data. Excessive alcohol use was responsible for an average of 178,307 deaths per year in the United States during 2020 and 2021 – a 29.3% increase from 2016 to 2017.
Alcohol causes harm through several distinct mechanisms:
Alcohol also interacts dangerously with opioids and benzodiazepines, compounding the respiratory depression that each produces on its own. For anyone who has been drinking heavily and wants to stop, medically supervised detox is the safest starting point – withdrawal from alcohol carries physical risks that make stopping without medical support genuinely dangerous.
Fentanyl is a synthetic opioid significantly more potent than morphine or heroin on their own. According to the 2024 toxicological review published in Toxics, it takes only 2 mg of fentanyl to be lethal for the average person with no prior opioid tolerance. A quantity small enough to be nearly invisible to the naked eye.
There are several features of fentanyl that make it particularly deadly in the current drug supply:
A 2026 study in medRxiv found that fentanyl-involved overdose deaths declined between 2023 and 2024 – driven primarily by changes in fentanyl potency in the illicit supply. That decline is meaningful, but fentanyl still remains the leading cause of drug overdose death in the United States, and naloxone access remains one of the most critical tools for reducing mortality at the community level. These findings highlight why compassionate, immediate support and harm reduction are so vital to giving clients the time and space needed to begin long-term recovery.
Prescription opioids – including hydrocodone, oxycodone, and morphine – were the primary driver of the overdose crisis in its early stages and remain a significant pathway into opioid dependence still today. A new concern is counterfeit pills designed to look like legitimate prescription medications that actually end up containing illicitly manufactured fentanyl.
Opioid use disorder, when left untreated, tends to follow a recognizable pattern:
Medication-Assisted Treatment (with buprenorphine, methadone, or naltrexone) is the evidence-based standard for opioid use disorder – and access to MAT consistently reduces overdose death risk. Serenity Lane provides MAT on-site with no third-party referral required.
Benzodiazepines like diazepam (Valium), alprazolam (Xanax), and lorazepam (Ativan) are commonly prescribed for anxiety, panic disorder, and sleep problems. They work by enhancing the effects of GABA, a neurotransmitter that slows activity in the central nervous system. Even when taken as prescribed, physical dependence can develop with regular use, and withdrawal carries serious medical risk – including seizures – even when tapering gradually.
The most significant danger of Benzos, however, is their interaction with opioids and alcohol. All three suppress respiratory function, and in combination, the effect can be fatal. What makes this especially concerning right now is how the benzodiazepine supply has shifted:
Benzodiazepine dependence is treatable; anyone who has been using benzodiazepines regularly – whether prescribed or from illicit sources – should consult a medical provider before attempting to stop, and should not stop abruptly on their own.
Cocaine is a stimulant with well-established cardiovascular effects. It constricts blood vessels, raises heart rate and blood pressure, and can trigger cardiac arrhythmias – sometimes in people with no prior history of heart problems and after relatively early use.
Methamphetamine works through a similar mechanism but causes a different pattern of damage over time. Where cocaine's cardiovascular risks are often acute and immediate, methamphetamine's accumulate progressively with continued use.
Both substances are dangerous in their own right, and both are showing up more often in Oregon's overdose data. The table below breaks down how cocaine, methamphetamine, and stimulants as a category compare across the most clinically relevant risk dimensions.
| Cocaine | Methamphetamine | |
|---|---|---|
| How it affects the heart | Causes artery spasm and irregular heartbeat, sometimes on the first use | Damages heart muscle progressively with continued use |
| Stroke risk | High – from sudden spikes in blood pressure and vessel constriction | High – from sustained elevated blood pressure and vascular damage |
| Brain effects | Disrupts dopamine; mood and cognition affected with chronic use | Severely depletes dopamine and serotonin systems; recovery of function can take months to years |
| Withdrawal | Crash, fatigue, and depression – primarily psychological | Intense depression, anhedonia, and cravings that can persist for weeks |
| Unique risk | Produces a heart-toxic compound when combined with alcohol | Frequently found alongside fentanyl in Oregon overdose deaths |
| Treatment | Behavioral therapy; no FDA-approved medication | Behavioral therapy; no FDA-approved medication |
Both substances respond well to evidence-based treatment when someone has access to it. However, there are currently no FDA-approved medications specifically for methamphetamine use disorder, which makes behavioral interventions, peer support, and structured programming particularly important to outcomes.
Oregon has seen a significant shift in its overdose landscape. 1,544 people died of a drug overdose in 2024 – a 16% decrease from 2023, marking the first year-over-year decline in more than a decade. But still, fentanyl and methamphetamine were present in more than 90% of fatal overdoses, and more than 62% of deaths involved multiple substances.
The Oregon Health Authority's 2025 overdose report provides the most current breakdown of how the state's overdose picture has changed. Here is what that data shows by substance:
| Substance | 2024 Pattern in Oregon |
|---|---|
| Fentanyl | Present in the majority of overdose deaths; primary driver of the 2024 decline when potency dropped |
| Methamphetamine | Co-involved in the majority of fentanyl-related deaths; stimulant-only deaths remained stable |
| Fentanyl + Methamphetamine combined | Present in 70% of all polysubstance overdose deaths |
| Cocaine | Deaths increased slightly since 2020, consistent with rising seizure data statewide |
| Heroin | Deaths dropped dramatically as fentanyl displaced heroin in the illicit supply |
The decline in Oregon overdose deaths is real, and it is the direct result of sustained investment in naloxone distribution, harm reduction programs, and treatment infrastructure.
However, even with this drop, Oregon's overdose death rates still remain significantly above pre-pandemic levels, and the combination of fentanyl and methamphetamine in the drug supply continues to make polysubstance exposure a serious risk for anyone using substances purchased from illicit sources.
Understanding what makes a drug dangerous is one part of a larger picture. If you or someone you love is dealing with substance use, knowing the risks is a starting point – and so is knowing that evidence-based treatment exists and that it works.
Addiction responds to clinical care – and the earlier that care begins, the more options are available. Whether the substance is alcohol, an opioid, a stimulant, or some combination, treatment can be shaped around what is actually happening and what you actually need.
Some things that can make a genuine difference in your recovery outcome:
Recovery is deeply personal and encompasses the whole person – mind, body, and spirit. Incorporating holistic wellness practices, mindfulness, and spiritual connection can help clients rebuild meaning, purpose, and inner strength as they heal.
You don't need to have everything figured out before you reach out. A single call can clarify what treatment might look like, what it costs, and what comes next.

Serenity Lane has been helping Oregonians recover from substance use disorders since 1973. Our programs span the full continuum of care – from medically supervised detox through residential treatment and outpatient programs. All programs are CARF-accredited, and our large, close-knit alumni community stays connected through weekly updates and events – ensuring that no one has to navigate through their recovery alone.
When you're ready to talk, Serenity Lane is here. Call us at 800-543-9905, or submit a confidential inquiry and we'll be in touch.
Serenity Lane: Finding Serenity in Long-Term Recovery